Apicidin is a histone deacetylase inhibitor with anti-invasive and anti-angiogenic potentials
- 12 February 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 315 (4) , 964-970
- https://doi.org/10.1016/j.bbrc.2004.01.149
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signalingOncogene, 2002
- Apicidin, a Histone Deacetylase Inhibitor, Induces Apoptosis and Fas/Fas Ligand Expression in Human Acute Promyelocytic Leukemia CellsJournal of Biological Chemistry, 2002
- Trichostatin A, an inhibitor of histone deacetylase, inhibits hypoxia-induced angiogenesisExpert Opinion on Investigational Drugs, 2001
- Apicidin, an inhibitor of histone deacetylase, prevents H-ras-induced invasive phenotypeCancer Letters, 2000
- Functional Characterization of the Spontaneously Transformed Human Umbilical Vein Endothelial Cell Line ECV304: Use in anin VitroModel of AngiogenesisExperimental Cell Research, 1996
- Synthesis and cellular characterization of the detransformation agent, (−)-depudecinChemistry & Biology, 1995
- Depudecin, a microbial metabolite containing two epoxide groups, exhibits anti-angiogenic activity in vivo.Biological & Pharmaceutical Bulletin, 1995
- Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells.Proceedings of the National Academy of Sciences, 1994
- A highly potent antiangiogenic activity of retinoidsCancer Letters, 1989
- ras GENESAnnual Review of Biochemistry, 1987